Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Complement-mediated serum sensitivity among spirochetes that cause Lyme disease.

van Dam AP, Oei A, Jaspars R, Fijen C, Wilske B, Spanjaard L, Dankert J.

Infect Immun. 1997 Apr;65(4):1228-36.

2.

Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation.

Alitalo A, Meri T, Rämö L, Jokiranta TS, Heikkilä T, Seppälä IJ, Oksi J, Viljanen M, Meri S.

Infect Immun. 2001 Jun;69(6):3685-91.

3.

Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates.

Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V.

Int Immunopharmacol. 2001 Mar;1(3):393-401. Review.

PMID:
11367524
5.

Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.

Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V.

Int J Med Microbiol. 2002 Jun;291 Suppl 33:141-6. Review.

PMID:
12141738
6.

Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi.

Breitner-Ruddock S, Würzner R, Schulze J, Brade V.

Med Microbiol Immunol. 1997 Mar;185(4):253-60.

PMID:
9138298
7.

Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.

Golubić D, Rijpkema S, Tkalec-Makovec N, Ruzić E.

Acta Med Croatica. 1998;52(1):7-13.

PMID:
9599811
8.

Species identification of Borrelia burgdorferi sensu lato from tick and human isolates in Styria (Austria) by PCR-RFLP analysis.

Stünzner D, Pierer K, Hubalek Z, Halouzka J, Aberer E, Millner MM, Marth E.

Wien Klin Wochenschr. 1999 Dec 10;111(22-23):994-6.

PMID:
10666817
9.

Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe.

Lovrich SD, Callister SM, Lim LC, DuChateau BK, Schell RF.

J Infect Dis. 1994 Jul;170(1):115-21.

PMID:
8014485
10.

Complement regulator-acquiring surface proteins of Borrelia burgdorferi: a new protein family involved in complement resistance.

Kraiczy P, Skerka C, Zipfel PF, Brade V.

Wien Klin Wochenschr. 2002 Jul 31;114(13-14):568-73. Review.

PMID:
12422603
12.

Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae.

Pietikäinen J, Meri T, Blom AM, Meri S.

Mol Immunol. 2010 Mar;47(6):1299-305. doi: 10.1016/j.molimm.2009.11.028. Epub 2009 Dec 21.

PMID:
20022381
13.

Sublethal concentrations of complement can effectively opsonize Borrelia burgdorferi.

Suhonen J, Hartiala K, Tuominen-Gustafsson H, Viljanen MK.

Scand J Immunol. 2002 Dec;56(6):554-60.

14.

Analysis of Borrelia burgdorferi sensu lato isolated from cerebrospinal fluid.

Ruzić-Sabljić E, Lotric-Furlan S, Maraspin V, Cimperman J, Pleterski-Rigler D, Strle F.

APMIS. 2001 Oct;109(10):707-13.

PMID:
11890575
15.

Growth inhibitory and bactericidal efficacy of sera from Lyme borreliosis patients on B. burgdorferi strains.

Kraiczy P, Peters S, Seitz C, Würzner R, Oschmann P, Brade V.

Wien Klin Wochenschr. 1998 Dec 23;110(24):886-93.

PMID:
10048171
16.

Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia.

Ruzić-Sabljić E, Maraspin V, Lotric-Furlan S, Jurca T, Logar M, Pikelj-Pecnik A, Strle F.

Wien Klin Wochenschr. 2002 Jul 31;114(13-14):544-50.

PMID:
12422599
17.

Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.

Ikushima M, Matsui K, Yamada F, Kawahashi S, Nishikawa SK.

FEMS Immunol Med Microbiol. 2000 Sep;29(1):15-21.

18.

The tick salivary protein Salp15 inhibits the killing of serum-sensitive Borrelia burgdorferi sensu lato isolates.

Schuijt TJ, Hovius JW, van Burgel ND, Ramamoorthi N, Fikrig E, van Dam AP.

Infect Immun. 2008 Jul;76(7):2888-94. doi: 10.1128/IAI.00232-08. Epub 2008 Apr 21.

19.

Complement-mediated killing of Borrelia burgdorferi by nonimmune sera from sika deer.

Nelson DR, Rooney S, Miller NJ, Mather TN.

J Parasitol. 2000 Dec;86(6):1232-8.

PMID:
11191897
20.

Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H.

Kraiczy P, Skerka C, Kirschfink M, Brade V, Zipfel PF.

Eur J Immunol. 2001 Jun;31(6):1674-84.

Supplemental Content

Support Center